Also known as Selzentry
Maraviroc (brand-named Selzentry, or Celsentri outside the U.S.) is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. It is also classed as an entry inhibitor. It also appeared to reduce graft-versus-host disease in patients treated with allogeneic bone marrow transplantation for leukemia, in a phase 1/2 study.Source: Wikipedia
Estimated Total Cost: $1029.87 for an average of 28 days supply
Patients are most commonly prescribed maraviroc to treat human immunodeficiency virus infection (hiv), rabies, blastomycosis, and west nile virus.